Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres (pages 1849–1858)
Mary F. Mulcahy, Robert J. Lewandowski, Saad M. Ibrahim, Kent T. Sato, Robert K. Ryu, Bassel Atassi, Steven Newman, Mark Talamonti, Reed A. Omary, Al Benson III and Riad Salem
Article first published online: 6 MAR 2009 | DOI: 10.1002/cncr.24224
The objective of the current study was to determine the safety and efficacy of Yttrium-90 (Y90) microsphere treatment in patients with liver-dominant colorectal metastases. The results indicated that Y90 liver therapy provided sustained disease stabilization with acceptable toxicity, and asymptomatic patients who had preserved liver function at the time of Y90 treatment appeared to benefit most.